Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
G2-M Checkpoint,4/200,4.8141201780116e-08,4.8141201780116e-07,0,0,404.061224489796,6808.0790652455,TOP2A;CDK1;CDC6;AURKB
AURKA human kinase ARCHS4 coexpression,4/299,2.41942146936208e-07,1.02153350928621e-06,0,0,267.118644067797,4069.43693385559,TOP2A;CDK1;CDC6;AURKB
TTK human kinase ARCHS4 coexpression,4/299,2.41942146936208e-07,1.02153350928621e-06,0,0,267.118644067797,4069.43693385559,TOP2A;CDK1;CDC6;AURKB
BUB1 human kinase ARCHS4 coexpression,4/299,2.41942146936208e-07,1.02153350928621e-06,0,0,267.118644067797,4069.43693385559,TOP2A;CDK1;CDC6;AURKB
NEK2 human kinase ARCHS4 coexpression,4/299,2.41942146936208e-07,1.02153350928621e-06,0,0,267.118644067797,4069.43693385559,CHAF1B;CDK1;CDC6;AURKB
BUB1B human kinase ARCHS4 coexpression,4/299,2.41942146936208e-07,1.02153350928621e-06,0,0,267.118644067797,4069.43693385559,TOP2A;CDK1;CDC6;AURKB
WEE1 human kinase ARCHS4 coexpression,4/299,2.41942146936208e-07,1.02153350928621e-06,0,0,267.118644067797,4069.43693385559,TOP2A;CDK1;CDC6;AURKB
MELK human kinase ARCHS4 coexpression,4/299,2.41942146936208e-07,1.02153350928621e-06,0,0,267.118644067797,4069.43693385559,TOP2A;CDK1;CDC6;AURKB
PLK1 human kinase ARCHS4 coexpression,4/299,2.41942146936208e-07,1.02153350928621e-06,0,0,267.118644067797,4069.43693385559,TOP2A;CDK1;CDC6;AURKB
PLK4 human kinase ARCHS4 coexpression,4/299,2.41942146936208e-07,1.02153350928621e-06,0,0,267.118644067797,4069.43693385559,TOP2A;CDK1;CDC6;AURKB
G0 and Early G1 Homo sapiens R-HSA-1538133,3/25,1.72215024715644e-08,1.60159972985549e-06,0,0,1361.79545454545,24344.9631758708,TOP2A;CDK1;CDC6
G0 and early G1 pathway,3/25,1.72215024715644e-08,1.65326423727018e-06,0,0,1361.79545454545,24344.9631758708,TOP2A;CDK1;CDC6
MAPK1 knockdown 96h A375,4/300,2.45201755283049e-07,2.91790088786828e-05,0,0,266.202702702703,4051.92044540389,CHAF1B;CDK1;CDC6;AURKB
FGFR1 knockdown 96h HT29,4/300,2.45201755283049e-07,2.91790088786828e-05,0,0,266.202702702703,4051.92044540389,TOP2A;CHAF1B;CDK1;CDC6
RXRA knockdown 96h A375,4/300,2.45201755283049e-07,2.91790088786828e-05,0,0,266.202702702703,4051.92044540389,TOP2A;CHAF1B;CDK1;AURKB
WEE1 knockdown 96h A375,4/300,2.45201755283049e-07,2.91790088786828e-05,0,0,266.202702702703,4051.92044540389,TOP2A;CHAF1B;CDK1;AURKB
SRC knockdown 96h HT29,4/300,2.45201755283049e-07,2.91790088786828e-05,0,0,266.202702702703,4051.92044540389,TOP2A;CHAF1B;CDK1;AURKB
STK3 knockdown 96h A549,4/300,2.45201755283049e-07,2.91790088786828e-05,0,0,266.202702702703,4051.92044540389,CHAF1B;CDK1;CDC6;AURKB
Metaphase/Anaphase Phase Transition,2/8,1.39910874621147e-06,3.54514206888363e-05,0,0,2221,29938.3584724232,CDK1;AURKB
Cell Cycle Overiew,3/107,1.47714252870151e-06,3.54514206888363e-05,0,0,286.889423076923,3851.60556476245,CDK1;CDC6;AURKB
E2F Targets,3/200,9.70634307108318e-06,4.85317153554159e-05,0,0,150.746192893401,1740.02274801128,TOP2A;CDK1;AURKB
Cell cycle,4/453,1.27554346259953e-06,6.12260862047775e-05,0,0,174.129175946548,2363.30524495093,TOP2A;CDK1;CDC6;AURKB
Cell Cycle, Mitotic Homo sapiens R-HSA-69278,4/462,1.37982547295854e-06,6.41618844925722e-05,0,0,170.628820960699,2302.38913036036,TOP2A;CDK1;CDC6;AURKB
Chromosome Condensation,2/15,5.24306953950488e-06,6.51809735780882e-05,0,0,1024.71794871795,12459.1391774979,CDK1;AURKB
Spindle Assembly,2/16,5.99148920325627e-06,6.51809735780882e-05,0,0,951.47619047619,11441.6634760018,CDK1;AURKB
Histone Phosphorylation,2/17,6.78968474771753e-06,6.51809735780882e-05,0,0,888,10567.2941691846,CDK1;AURKB
Mitotic G1-G1/S phases Homo sapiens R-HSA-453279,3/136,3.04492180117697e-06,7.21349567618501e-05,0,0,224.007518796992,2845.3514197798,TOP2A;CDK1;CDC6
Cell Cycle Homo sapiens R-HSA-1640170,4/566,3.10257878545592e-06,7.21349567618501e-05,0,0,138.313167259786,1754.26420286887,TOP2A;CDK1;CDC6;AURKB
PBK human kinase ARCHS4 coexpression,3/299,3.23521721312637e-05,7.23166200581188e-05,0,0,99.8260135135135,1032.08412285573,TOP2A;CDC6;AURKB
CHEK1 human kinase ARCHS4 coexpression,3/299,3.23521721312637e-05,7.23166200581188e-05,0,0,99.8260135135135,1032.08412285573,CHAF1B;CDC6;AURKB
CHEK2 human kinase ARCHS4 coexpression,3/299,3.23521721312637e-05,7.23166200581188e-05,0,0,99.8260135135135,1032.08412285573,CHAF1B;CDC6;AURKB
VRK1 human kinase ARCHS4 coexpression,3/299,3.23521721312637e-05,7.23166200581188e-05,0,0,99.8260135135135,1032.08412285573,CDK1;CDC6;AURKB
AURKB human kinase ARCHS4 coexpression,3/299,3.23521721312637e-05,7.23166200581188e-05,0,0,99.8260135135135,1032.08412285573,TOP2A;CDK1;CDC6
CDK1 human kinase ARCHS4 coexpression,3/299,3.23521721312637e-05,7.23166200581188e-05,0,0,99.8260135135135,1032.08412285573,TOP2A;CDC6;AURKB
CDC7 human kinase ARCHS4 coexpression,3/299,3.23521721312637e-05,7.23166200581188e-05,0,0,99.8260135135135,1032.08412285573,CDK1;CDC6;AURKB
CSNK2A2 human kinase ARCHS4 coexpression,3/299,3.23521721312637e-05,7.23166200581188e-05,0,0,99.8260135135135,1032.08412285573,CDK1;CDC6;AURKB
Mitotic G1-G1/S phases,3/135,2.97797802899339e-06,9.52952969277883e-05,0,0,225.715909090909,2872.06926804362,TOP2A;CDK1;CDC6
APC/C-FZR1 Complex,2/23,1.26233161546432e-05,0.000100986529237146,0,0,634.095238095238,7152.5720705602,CDK1;AURKB
G1/S-Specific Transcription Homo sapiens R-HSA-69205,2/17,6.78968474771753e-06,0.000126288136307546,0,0,888,10567.2941691846,CDK1;CDC6
G1/S-specific transcription,2/17,6.78968474771753e-06,0.000162952433945221,0,0,888,10567.2941691846,CDK1;CDC6
APC/C-CDC20 Complex,2/33,2.63181604025387e-05,0.000167761581316982,0,0,429.333333333333,4527.42791184729,CDK1;AURKB
SCF/BTRC Complex,2/34,2.79602635528303e-05,0.000167761581316982,0,0,415.895833333333,4360.55394628301,CDK1;AURKB
PIN1,3/145,3.69293433679279e-06,0.000253138287127243,0,0,209.714788732394,2623.34099937961,TOP2A;CDK1;AURKB
CDK1,4/659,5.68850083432006e-06,0.000253138287127243,0,0,118.106870229008,1426.38420913526,TOP2A;CHAF1B;CDK1;AURKB
RB1,3/209,1.10762483304562e-05,0.000328595367136867,0,0,144.094660194175,1644.2220244443,TOP2A;CDK1;AURKB
FOXM1 transcription factor network Homo sapiens c51cda49-6192-11e5-8ac5-06603eb7f303,2/40,3.88520160544551e-05,0.000388520160544551,0,0,350.122807017544,3555.75990366199,CDK1;AURKB
E2F mediated regulation of DNA replication Homo sapiens R-HSA-113510,2/33,2.63181604025387e-05,0.000407931486239351,0,0,429.333333333333,4527.42791184729,CDK1;CDC6
JAK1 druginhibition 165 GSE38335,3/300,3.26764879945848e-05,0.000424794343929602,0,0,99.4848484848485,1027.56455084581,TOP2A;CHAF1B;AURKB
JAK2 druginhibition 167 GSE38335,3/300,3.26764879945848e-05,0.000424794343929602,0,0,99.4848484848485,1027.56455084581,TOP2A;CHAF1B;AURKB
ATM Signaling Network in Development and Disease  WP3878,2/45,4.92876074570024e-05,0.00048946675024924,0,0,309.333333333333,3067.91785043298,CDK1;AURKB
Regulation of Microtubule Cytoskeleton WP2038,2/46,5.15228158157094e-05,0.00048946675024924,0,0,302.287878787879,2984.63508563263,CDK1;AURKB
E2F-mediated regulation of DNA replication,2/33,2.63181604025387e-05,0.000505308679728744,0,0,429.333333333333,4527.42791184729,CDK1;CDC6
AURKA druginhibition 196 GSE57810,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,TOP2A;CDC6;AURKB
SYK knockdown 190 GSE54065,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,CDK1;CDC6;AURKB
ABL1 knockdown 96h A375,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,TOP2A;CDC6;AURKB
CSNK1A1 knockdown 96h A375,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,CHAF1B;CDK1;AURKB
MAP2K2 knockdown 96h A375,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,CHAF1B;CDK1;AURKB
AURKB knockdown 96h HT29,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,CHAF1B;CDK1;AURKB
PKN2 knockdown 96h A375,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,TOP2A;CDK1;AURKB
PRKACB knockdown 96h A375,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,CHAF1B;CDK1;AURKB
PRKCA knockdown 96h A375,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,CHAF1B;CDK1;AURKB
PRKDC knockdown 96h A375,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,TOP2A;CDK1;AURKB
PTK2 knockdown 96h A375,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,CHAF1B;CDK1;CDC6
ADCK3 knockdown 96h HCC515,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,TOP2A;CDK1;CDC6
GPR56 knockdown 96h HT29,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,CHAF1B;CDK1;CDC6
SRC knockdown 96h A375,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,CHAF1B;CDK1;CDC6
TAOK3 knockdown 96h A375,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,TOP2A;CDK1;AURKB
ABL2 knockdown 96h A549,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,TOP2A;CDK1;AURKB
FZD5 knockdown 96h HCC515,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,TOP2A;CHAF1B;CDC6
RAF1 knockdown 96h PC3,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,CHAF1B;CDK1;CDC6
MST1R knockdown 96h HT29,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,CHAF1B;CDK1;CDC6
NEK7 knockdown 96h HT29,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,TOP2A;CHAF1B;CDK1
CD97 knockdown 96h A549,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,TOP2A;CDK1;CDC6
DYRK3 knockdown 96h A549,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,TOP2A;CDK1;CDC6
ERBB3 knockdown 96h A549,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,TOP2A;CDK1;CDC6
RARA knockdown 96h HT29,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,TOP2A;CHAF1B;CDC6
RET knockdown 96h HT29,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,TOP2A;CDK1;CDC6
MST1R knockdown 96h HCC515,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,CHAF1B;CDK1;CDC6
NR3C1 knockdown 96h HCC515,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,TOP2A;CHAF1B;CDK1
WEE1 knockdown 96h HT29,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,CHAF1B;CDK1;AURKB
MST1R knockdown 96h A549,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,CHAF1B;CDK1;CDC6
TESK1 knockdown 96h HCC515,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,TOP2A;CHAF1B;CDK1
PIK3R4 knockdown 96h A549,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,TOP2A;CHAF1B;CDK1
RXRA knockdown 96h A549,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,TOP2A;CHAF1B;CDK1
SLK knockdown 96h A549,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,TOP2A;CHAF1B;CDK1
STK33 knockdown 96h A549,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,TOP2A;CDK1;CDC6
TGFBR2 knockdown 96h A549,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,TOP2A;CHAF1B;CDC6
TTK knockdown 96h A549,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,TOP2A;CHAF1B;CDK1
VRK2 knockdown 96h A549,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,TOP2A;CHAF1B;AURKB
WEE1 knockdown 96h A549,3/300,3.26764879945848e-05,0.000555500295907941,0,0,99.4848484848485,1027.56455084581,CHAF1B;CDK1;AURKB
FOXM1 transcription factor network,2/41,4.08403579697154e-05,0.000616666095614698,0,0,341.128205128205,3447.38699212753,CDK1;AURKB
G2/M checkpoints,2/43,4.49652361385718e-05,0.000616666095614698,0,0,324.455284552846,3247.67439640328,CDK1;CDC6
SUMOylation of DNA replication proteins Homo sapiens R-HSA-4615885,2/44,4.71017426068059e-05,0.000625780294633278,0,0,316.714285714286,3155.48794866346,TOP2A;AURKB
E2F transcription factor network Homo sapiens bb4d0fd3-6191-11e5-8ac5-06603eb7f303,2/72,0.000126909065898155,0.000634545329490776,0,0,189.761904761905,1702.55135151923,CDK1;CDC6
FAM131B,2/28,1.88507774199287e-05,0.000980240425836293,0,0,512.025641025641,5570.30462567196,TOP2A;CDC6
Retinoblastoma gene in cancer WP2446,2/87,0.000185467610680479,0.00117462820097637,0,0,156.156862745098,1341.79818985462,TOP2A;CDK1
CDK1,3/494,0.000144332155594891,0.00139995407743327,0,0,59.5845213849287,526.929355918942,TOP2A;CHAF1B;CDK1
PLK1,2/77,0.00014520749739458,0.00139995407743327,0,0,177.066666666667,1564.79954394131,TOP2A;CDC6
GSK3B,3/527,0.00017485819782631,0.00139995407743327,0,0,55.7375954198473,482.215769331501,TOP2A;CHAF1B;CDC6
WEE2,1/1,0.000249991799541656,0.00139995407743327,0,0,19995,165840.178437256,CDK1
PKMYT1,1/1,0.000249991799541656,0.00139995407743327,0,0,19995,165840.178437256,CDK1
ESPL1-CDC2 complex (human),1/2,0.000499936218598775,0.00144953199696337,0,0,4998.5,37993.7486073611,CDK1
CyclinB1-Cdc2 complex (mouse),1/2,0.000499936218598775,0.00144953199696337,0,0,4998.5,37993.7486073611,CDK1
CCNB2-CDC2 complex (human),1/2,0.000499936218598775,0.00144953199696337,0,0,4998.5,37993.7486073611,CDK1
CCNB1-CDC2 complex (human),1/2,0.000499936218598775,0.00144953199696337,0,0,4998.5,37993.7486073611,CDK1
CDC2-CCNA2 complex (human),1/2,0.000499936218598775,0.00144953199696337,0,0,4998.5,37993.7486073611,CDK1
Chromatin assembly complex (CAF-1 complex) (human),1/3,0.000749831471870374,0.00144953199696337,0,0,2499.125,17982.8589978205,CHAF1B
Chromosomal passenger complex CPC (INCENP, BIRC5, AURKB) (human),1/3,0.000749831471870374,0.00144953199696337,0,0,2499.125,17982.8589978205,AURKB
MCM8-ORC2-CDC6 complex (human),1/3,0.000749831471870374,0.00144953199696337,0,0,2499.125,17982.8589978205,CDC6
CRM1-Survivin-AuroraB mitotic complex (human),1/3,0.000749831471870374,0.00144953199696337,0,0,2499.125,17982.8589978205,AURKB
RalBP1-CDC2-CCNB1 complex (human),1/3,0.000749831471870374,0.00144953199696337,0,0,2499.125,17982.8589978205,CDK1
CDC2-CCNB1-CCNF complex (human),1/3,0.000749831471870374,0.00144953199696337,0,0,2499.125,17982.8589978205,CDK1
CDC2-CCNB1-PTCH1 complex (human),1/3,0.000749831471870374,0.00144953199696337,0,0,2499.125,17982.8589978205,CDK1
CDC2-CCNA2-CDK2 complex (human),1/3,0.000749831471870374,0.00144953199696337,0,0,2499.125,17982.8589978205,CDK1
RasGAP-AURKA/AURKB-survivin complex (human),1/4,0.000999677239285086,0.00144953199696337,0,0,1666,11508.8581009313,AURKB
BIRC5-AURKB-INCENP-EVI5 complex (human),1/4,0.000999677239285086,0.00144953199696337,0,0,1666,11508.8581009313,AURKB
BRCA1-IRIS-pre-replication complex (human),1/4,0.000999677239285086,0.00144953199696337,0,0,1666,11508.8581009313,CDC6
Chromosomal passenger complex CPC (INCENP, CDCA8, BIRC5, AURKB) (human),1/4,0.000999677239285086,0.00144953199696337,0,0,1666,11508.8581009313,AURKB
CDC2-PCNA-CCNB1-GADD45A complex (human),1/4,0.000999677239285086,0.00144953199696337,0,0,1666,11508.8581009313,CDK1
CDC2-PCNA-CCNB1-GADD45B complex (human),1/4,0.000999677239285086,0.00144953199696337,0,0,1666,11508.8581009313,CDK1
CDC2-PCNA-CCNB1-GADD45G complex (human),1/4,0.000999677239285086,0.00144953199696337,0,0,1666,11508.8581009313,CDK1
E2F transcription factor network,2/74,0.000134081715770872,0.00160898058925047,0,0,184.472222222222,1644.9500813633,CDK1;CDC6
Cell cycle WP179,2/120,0.000352812323035563,0.00167585853441893,0,0,112.299435028249,892.732703189325,CDK1;CDC6
APC/C-mediated degradation of cell cycle proteins,2/82,0.000164727629854126,0.00175709471844401,0,0,165.958333333333,1445.69908386245,CDK1;AURKB
APC/C-mediated degradation of cell cycle proteins Homo sapiens R-HSA-174143,2/85,0.000177025355075892,0.00182926200245089,0,0,159.935742971888,1381.71968341399,CDK1;AURKB
Regulation of mitotic cell cycle Homo sapiens R-HSA-453276,2/85,0.000177025355075892,0.00182926200245089,0,0,159.935742971888,1381.71968341399,CDK1;AURKB
SUMO E3 ligases SUMOylate target proteins Homo sapiens R-HSA-3108232,2/96,0.000225867685995685,0.00193760383614405,0,0,141.141843971631,1184.9649875808,TOP2A;AURKB
Resolution of Sister Chromatid Cohesion Homo sapiens R-HSA-2500257,2/99,0.000240209471381829,0.00193760383614405,0,0,136.756013745704,1139.72451159492,CDK1;AURKB
SUMOylation Homo sapiens R-HSA-2990846,2/101,0.000250013398212136,0.00193760383614405,0,0,133.979797979798,1111.22791504867,TOP2A;AURKB
Cell cycle kinase complex CDC2 (human),1/6,0.00149921982162069,0.00197624431031819,0,0,999.5,6499.55901988972,CDK1
ASF1-interacting protein complex (human),1/6,0.00149921982162069,0.00197624431031819,0,0,999.5,6499.55901988972,CHAF1B
Mitotic Prometaphase Homo sapiens R-HSA-68877,2/107,0.000280589014069377,0.0020072906391117,0,0,126.285714285714,1032.84281081247,CDK1;AURKB
G1/S Transition Homo sapiens R-HSA-69206,2/112,0.000307400495633069,0.00204201757813396,0,0,120.515151515152,974.649309044046,CDK1;CDC6
Toposome (human),1/7,0.00174891651493262,0.00211327412221025,0,0,832.875,5287.7224998036,TOP2A
ASF1-histone containing complex (human),1/7,0.00174891651493262,0.00211327412221025,0,0,832.875,5287.7224998036,CHAF1B
CHEK1,2/137,0.000459552482387706,0.00214457825114263,0,0,98.0740740740741,753.724504153147,CDK1;AURKB
Mitotic Spindle,2/199,0.000965810507198486,0.00243867045986358,0,0,66.9983079526227,465.138627544557,TOP2A;CDK1
Estrogen Response Late,2/200,0.000975468183945434,0.00243867045986358,0,0,66.6565656565657,462.102841378486,TOP2A;CDC6
MYC,3/498,0.000147828791197604,0.00269457662699552,0,0,59.0909090909091,521.149659139964,TOP2A;CDK1;CDC6
TP53,3/502,0.000151380709381771,0.00269457662699552,0,0,58.6052104208417,515.474590068137,TOP2A;CDK1;AURKB
Histone H3.1 complex (human),1/10,0.00249770786419674,0.00289734112246822,0,0,555.166666666667,3326.77064151216,CHAF1B
Cell cycle checkpoints,2/117,0.00033542073861748,0.0032200390907278,0,0,115.246376811594,921.985406229304,CDK1;CDC6
down 60min BMP4 vs ctrl hESC (Human) [19664995],3/561,0.00021045763808434,0.00323597619799828,0,0,52.25,442.36031734849,TOP2A;CHAF1B;CDC6
down 240min BMP4 vs ctrl hESC (Human) [19664995],3/610,0.000269664683166524,0.00323597619799828,0,0,47.9110378912685,393.748781597602,TOP2A;CHAF1B;CDC6
G2/M Checkpoints Homo sapiens R-HSA-69481,2/150,0.00055053770300056,0.00324262819618375,0,0,89.4009009009009,670.919352240136,CDK1;CDC6
Regulation of TP53 Activity Homo sapiens R-HSA-5633007,2/151,0.000557871517623011,0.00324262819618375,0,0,88.7964205816555,665.207895910229,CDK1;AURKB
Cell cycle,2/124,0.000376676288753193,0.00339008659877874,0,0,108.595628415301,856.181442624483,CDK1;CDC6
SRPK1 human kinase ARCHS4 coexpression,2/299,0.00216218481049296,0.00342345928328053,0,0,44.2154882154882,271.334360373235,CDC6;AURKB
NEK4 human kinase ARCHS4 coexpression,2/299,0.00216218481049296,0.00342345928328053,0,0,44.2154882154882,271.334360373235,CDK1;CDC6
MASTL human kinase ARCHS4 coexpression,2/299,0.00216218481049296,0.00342345928328053,0,0,44.2154882154882,271.334360373235,CDK1;AURKB
CSNK2A1 human kinase ARCHS4 coexpression,2/299,0.00216218481049296,0.00342345928328053,0,0,44.2154882154882,271.334360373235,CDC6;AURKB
GSG2 human kinase ARCHS4 coexpression,2/299,0.00216218481049296,0.00342345928328053,0,0,44.2154882154882,271.334360373235,CDC6;AURKB
TGFBR1 human kinase ARCHS4 coexpression,2/299,0.00216218481049296,0.00342345928328053,0,0,44.2154882154882,271.334360373235,TOP2A;CDK1
PKMYT1 human kinase ARCHS4 coexpression,2/299,0.00216218481049296,0.00342345928328053,0,0,44.2154882154882,271.334360373235,CDC6;AURKB
DNA synthesome complex (mouse),1/13,0.00324605087508978,0.0034864990880594,0,0,416.3125,2385.60223672184,TOP2A
RC complex during G2/M-phase of cell cycle (human),1/13,0.00324605087508978,0.0034864990880594,0,0,416.3125,2385.60223672184,CDK1
CDC25A,1/8,0.00199856343165899,0.00399712686331798,0,0,713.857142857143,4436.8553176414,CDK1
WEE1,1/4,0.000999677239285086,0.00399870895714034,0,0,1666,11508.8581009313,CDK1
Cell Cycle Checkpoints Homo sapiens R-HSA-69620,2/182,0.000808844439672201,0.0044248548758538,0,0,73.3888888888889,522.521839634704,CDK1;CDC6
CSNK2A2,2/229,0.00127595327997004,0.00446583647989515,0,0,58.0558002936858,386.887435732569,TOP2A;CDK1
HIST1H3A,2/122,0.000364647899802241,0.00464295650604237,0,0,110.416666666667,874.122190387737,CHAF1B;AURKB
GSK3B,3/696,0.000398163431370432,0.00464295650604237,0,0,41.7792207792208,327.074813419657,TOP2A;CHAF1B;CDC6
TOP1,2/136,0.000452889084648196,0.00464295650604237,0,0,98.8109452736318,760.830772011607,TOP2A;CDK1
NPM1,2/144,0.000507538950537998,0.00464295650604237,0,0,93.2065727699531,707.059198354805,TOP2A;CDK1
PCNA,2/146,0.000521680506296896,0.00464295650604237,0,0,91.9027777777778,694.643029909295,CDK1;CDC6
DNA synthesome complex (17 subunits) (human),1/18,0.00449229270839297,0.00465273173369272,0,0,293.794117647059,1588.07239728978,TOP2A
DNA replication Homo sapiens P00017,1/19,0.00474139160939957,0.00474139160939957,0,0,277.458333333333,1484.79734988759,TOP2A
SUMO2,2/162,0.000641693526274949,0.00499589449677603,0,0,82.6458333333333,607.562557815676,TOP2A;CHAF1B
PLK1,2/166,0.000673603752374296,0.00499589449677603,0,0,80.6138211382114,588.71213702385,TOP2A;CDC6
PPP1CA,2/184,0.000826602571892155,0.00565904837680014,0,0,72.5750915750916,515.151538482769,CDK1;AURKB
up M-phase HeLa (Human) [18669648],4/2252,0.000729719477579671,0.00583775582063737,0,0,31.5782918149466,228.085276876291,TOP2A;CHAF1B;CDC6;AURKB
CCNA2,1/12,0.00299665302989365,0.0059933060597873,0,0,454.181818181818,2638.91411927659,CDK1
Cyclin B2 mediated events Homo sapiens R-HSA-157881,1/5,0.0012494733811349,0.00611584339187081,0,0,1249.4375,8352.53105828692,CDK1
G2/M DNA replication checkpoint Homo sapiens R-HSA-69478,1/5,0.0012494733811349,0.00611584339187081,0,0,1249.4375,8352.53105828692,CDK1
VIM,2/199,0.000965810507198486,0.00613979536719038,0,0,66.9983079526227,465.138627544557,CDK1;AURKB
CSNK2A1,2/286,0.00198054542374957,0.00616169687388757,0,0,46.2699530516432,288.001909447771,TOP2A;CDK1
cdc25 and chk1 Regulatory Pathway in response to DNA damage Homo sapiens h cdc25Pathway,1/7,0.00174891651493262,0.00641372034385287,0,0,832.875,5287.7224998036,CDK1
BTG family proteins and cell cycle regulation Homo sapiens h btg2Pathway,1/9,0.00224816055240216,0.00641372034385287,0,0,624.59375,3808.54966343072,CHAF1B
Sonic Hedgehog Receptor Ptc1 Regulates cell cycle Homo sapiens h ptc1Pathway,1/9,0.00224816055240216,0.00641372034385287,0,0,624.59375,3808.54966343072,CDK1
Regulation of Splicing through Sam68 Homo sapiens h sam68Pathway,1/10,0.00249770786419674,0.00641372034385287,0,0,555.166666666667,3326.77064151216,CDK1
Protein Kinase A at the Centrosome Homo sapiens h akapCentrosomePathway,1/12,0.00299665302989365,0.00641372034385287,0,0,454.181818181818,2638.91411927659,CDK1
RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage Homo sapiens h rbPathway,1/13,0.00324605087508978,0.00641372034385287,0,0,416.3125,2385.60223672184,CDK1
AKAP95 role in mitosis and chromosome dynamics Homo sapiens h akap95Pathway,1/14,0.00349539889312047,0.00641372034385287,0,0,384.269230769231,2173.54503857692,CDK1
Estrogen-responsive protein Efp controls cell cycle and breast tumors growth Homo sapiens h EfpPathway,1/15,0.00374469708393798,0.00641372034385287,0,0,356.803571428571,1993.60946675892,CDK1
CDK Regulation of DNA Replication Homo sapiens h mcmPathway,1/18,0.00449229270839297,0.00641372034385287,0,0,293.794117647059,1588.07239728978,CDC6
Regulation of cell cycle progression by Plk3 Homo sapiens h plk3Pathway,1/18,0.00449229270839297,0.00641372034385287,0,0,293.794117647059,1588.07239728978,CDK1
Cell Cycle: G2/M Checkpoint Homo sapiens h g2Pathway,1/22,0.00548838944332051,0.00641372034385287,0,0,237.785714285714,1237.70327900363,CDK1
Cyclins and Cell Cycle Regulation Homo sapiens h cellcyclePathway,1/23,0.00573728911332865,0.00641372034385287,0,0,226.965909090909,1171.31850515834,CDK1
How Progesterone Initiates the Oocyte Maturation Homo sapiens h mPRPathway,1/23,0.00573728911332865,0.00641372034385287,0,0,226.965909090909,1171.31850515834,CDK1
Stathmin and breast cancer resistance to antimicrotubule agents Homo sapiens h stathminPathway,1/24,0.00598613898759602,0.00641372034385287,0,0,217.086956521739,1111.11804759418,CDK1
Cell Cycle: G1/S Check Point  Homo sapiens h g1Pathway,1/26,0.00648368936979889,0.00648368936979889,0,0,199.7,1006.18157701364,CDK1
BRCA1,2/216,0.00113638140628158,0.00674252967727073,0,0,61.6230529595016,417.798523140778,TOP2A;CDK1
Phosphorylation of Emi1 Homo sapiens R-HSA-176417,1/6,0.00149921982162069,0.00697137217053623,0,0,999.5,6499.55901988972,CDK1
STK4,1/10,0.00249770786419674,0.0069928863666758,0,0,555.166666666667,3326.77064151216,AURKB
EIF2AK2,1/11,0.00274720535833692,0.0069928863666758,0,0,499.625,2946.37411950643,CDK1
up metaphase anaphase telophase 60min noscapine release vs ctrl HeLa (Human) [19691289],2/229,0.00127595327997004,0.00728541268371995,0,0,58.0558002936858,386.887435732569,TOP2A;AURKB
up 10min PPase inhibitors vs ctrl Hepa1-6 (Mouse) [18846507],3/1098,0.00151779430910832,0.00728541268371995,0,0,25.8904109589041,168.041637516767,TOP2A;CHAF1B;CDK1
M Phase Homo sapiens R-HSA-68886,2/268,0.00174183443190075,0.00739314708585152,0,0,49.4461152882206,314.122094586757,CDK1;AURKB
Activation of NIMA Kinases NEK9, NEK6, NEK7 Homo sapiens R-HSA-2980767,1/7,0.00174891651493262,0.00739314708585152,0,0,832.875,5287.7224998036,CDK1
CDC5L complex (human),1/30,0.00747819282854126,0.00747819282854126,0,0,172.120689655172,842.662296146542,TOP2A
CDC5L,1/33,0.00822354796912648,0.00822354796912648,0,0,155.9609375,748.730022278245,TOP2A
DNA replication,2/207,0.00104438881242172,0.00856781747063929,0,0,64.3577235772358,441.772230056286,CDC6;AURKB
Chk1/Chk2(Cds1)-mediated inactivation of cyclin B-Cdk1 complex,1/5,0.0012494733811349,0.00856781747063929,0,0,1249.4375,8352.53105828692,CDK1
ERK activation,1/5,0.0012494733811349,0.00856781747063929,0,0,1249.4375,8352.53105828692,CDK1
Cyclin B2-mediated events,1/5,0.0012494733811349,0.00856781747063929,0,0,1249.4375,8352.53105828692,CDK1
MAPK14,2/396,0.00375879976125816,0.00877053277626905,0,0,33.165820642978,185.186519663304,CHAF1B;CDC6
ERBB2,1/17,0.00424314398899693,0.0088505976708792,0,0,312.171875,1705.22350136349,CDK1
PLK3,1/18,0.00449229270839297,0.0088505976708792,0,0,293.794117647059,1588.07239728978,TOP2A
MAP3K8,1/19,0.00474139160939957,0.0088505976708792,0,0,277.458333333333,1484.79734988759,CDK1
GPR3 in Oocyte Meiotic Arrest,1/7,0.00174891651493262,0.00888266714393918,0,0,832.875,5287.7224998036,CDK1
HPV E4 Contribution to Life Cycle of Virus and Cell,1/8,0.00199856343165899,0.00888266714393918,0,0,713.857142857143,4436.8553176414,CDK1
Proteins Involved in Glioma,2/290,0.00203561122048606,0.00888266714393918,0,0,45.6180555555556,282.693226832104,CDK1;AURKB
MASTL Facilitates Mitotic Progression Homo sapiens R-HSA-2465910,1/10,0.00249770786419674,0.00912464636876192,0,0,555.166666666667,3326.77064151216,CDK1
E2F-enabled inhibition of pre-replication complex formation Homo sapiens R-HSA-113507,1/10,0.00249770786419674,0.00912464636876192,0,0,555.166666666667,3326.77064151216,CDK1
MAPK3 (ERK1) activation Homo sapiens R-HSA-110056,1/10,0.00249770786419674,0.00912464636876192,0,0,555.166666666667,3326.77064151216,CDK1
CDC6 association with the ORC:origin complex Homo sapiens R-HSA-68689,1/11,0.00274720535833692,0.00912464636876192,0,0,499.625,2946.37411950643,CDC6
Recruitment of NuMA to mitotic centrosomes Homo sapiens R-HSA-380320,1/11,0.00274720535833692,0.00912464636876192,0,0,499.625,2946.37411950643,CDK1
Condensation of Prometaphase Chromosomes Homo sapiens R-HSA-2514853,1/11,0.00274720535833692,0.00912464636876192,0,0,499.625,2946.37411950643,CDK1
PTK2 knockdown 96h MCF7,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
ARAF knockdown 96h A375,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,TOP2A;CHAF1B
ATR knockdown 96h A375,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
CHEK1 knockdown 96h A375,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDC6;AURKB
GPR78 knockdown 96h HA1E,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;CDC6
EIF2AK3 knockdown 96h A375,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
FGFR3 knockdown 96h A375,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,TOP2A;CDC6
LGR5 knockdown 96h HA1E,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
C9ORF96 knockdown 96h PC3,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
MAP2K6 knockdown 96h HA1E,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;CDC6
CAMK2D knockdown 96h PC3,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
GPR114 knockdown 96h A375,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;AURKB
GPR125 knockdown 96h A375,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
CDK4 knockdown 96h PC3,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
MAPKAPK2 knockdown 96h HA1E,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
NEK7 knockdown 96h HA1E,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
ERG knockdown 96h PC3,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,TOP2A;CDK1
KCNJ11 knockdown 96h A375,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;AURKB
ABL1 knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,TOP2A;CDK1
FZD7 knockdown 96h PC3,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
FZD8 knockdown 96h PC3,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;CDC6
ADRA2C knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;CDC6
AKT1 knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;CDC6
MAP3K4 knockdown 96h A375,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;AURKB
AR knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
GPR111 knockdown 96h PC3,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
MAP3K8 knockdown 96h A375,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;AURKB
ATR knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;CDC6
AURKA knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
GPR119 knockdown 96h PC3,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;CDC6
BMPR1A knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
BRAF knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
MAPK8 knockdown 96h A375,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
C9ORF96 knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;CDC6
PRKCZ knockdown 96h HA1E,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
CDK1 knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;CDC6
CDK11B knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDC6;AURKB
PTK2 knockdown 96h HA1E,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;CDC6
MST1R knockdown 96h A375,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
CDK7 knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;AURKB
NR1D2 knockdown 96h A375,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
CSNK1D knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;AURKB
NR2F1 knockdown 96h A375,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;AURKB
NR2F6 knockdown 96h A375,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;AURKB
JAK1 knockdown 96h PC3,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,TOP2A;CHAF1B
LGR6 knockdown 96h PC3,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
PLK2 knockdown 96h A375,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
MAP2K6 knockdown 96h PC3,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;AURKB
PPARG knockdown 96h A375,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;AURKB
PRKAA1 knockdown 96h A375,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
GABRG1 knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDC6;AURKB
PRKCB knockdown 96h A375,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
GPR115 knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,TOP2A;CDK1
PRPF4B knockdown 96h A375,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;AURKB
RIOK2 knockdown 96h A375,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;AURKB
GPR156 knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDC6;AURKB
RIOK3 knockdown 96h A375,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
GPR35 knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
NOX1 knockdown 96h PC3,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
GPR87 knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,TOP2A;CDK1
SCNN1A knockdown 96h A375,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;AURKB
GPRC5C knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
HNF4A knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;CDC6
OR5W2 knockdown 96h PC3,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
LCK knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;CDC6
PDPK1 knockdown 96h PC3,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,TOP2A;CHAF1B
PHKG2 knockdown 96h PC3,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,TOP2A;CHAF1B
LYN knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
PRKAA1 knockdown 96h PC3,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;CDC6
VRK2 knockdown 96h A375,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,TOP2A;CDK1
MAP3K4 knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
PRKCB knockdown 96h PC3,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;CDC6
MAPK13 knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;CDC6
AKT3 knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
PTGFR knockdown 96h PC3,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
ATR knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,TOP2A;CDK1
AURKA knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;CDC6
AURKB knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;AURKB
BMPR1A knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
BRAF knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,TOP2A;CDC6
ROCK1 knockdown 96h PC3,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,TOP2A;CHAF1B
NEK2 knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
CHEK1 knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
CHEK2 knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
SNRK knockdown 96h PC3,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
NUAK1 knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
CSNK1E knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
EIF2AK3 knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
EMR1 knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,TOP2A;CDK1
PIK3CA knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;CDC6
ERBB4 knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,TOP2A;CDC6
VRK3 knockdown 96h PC3,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
PTK2 knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
GPER knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,TOP2A;CDK1
RIOK3 knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
GPR125 knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;AURKB
GPR153 knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
RXRA knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;AURKB
SCN9A knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDC6;AURKB
SCNN1A knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;AURKB
GPR37 knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDC6;AURKB
GPR64 knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
STK3 knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;AURKB
STRADB knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDC6;AURKB
TBK1 knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,TOP2A;CHAF1B
ITPR3 knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
VRK3 knockdown 96h HT29,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;CDC6
KSR2 knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,TOP2A;CDK1
MAP3K4 knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;CDC6
MTOR knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
SCNN1A knockdown 96h HCC515,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
NR2C2 knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;AURKB
NR3C1 knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
SRC knockdown 96h HCC515,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
STK10 knockdown 96h HCC515,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;CDC6
STK3 knockdown 96h HCC515,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
ERBB3 knockdown 96h MCF7,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,TOP2A;CHAF1B
ESR1 knockdown 96h MCF7,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
PIM2 knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
PTK2 knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
ROCK2 knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,TOP2A;AURKB
SRC knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,TOP2A;CHAF1B
TLK2 knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
VDR knockdown 96h A549,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
MAPKAPK5 knockdown 96h MCF7,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
NMUR2 knockdown 96h MCF7,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,TOP2A;CHAF1B
CDK1 knockdown 96h HA1E,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CDK1;CDC6
CDK7 knockdown 96h HA1E,2/300,0.00217647688711148,0.00914120292586823,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
CDK7,1/21,0.00523943997247116,0.00916901995182453,0,0,249.6875,1311.24405900402,CDK1
Transcriptional Regulation by TP53 Homo sapiens R-HSA-3700989,2/348,0.00291587768312292,0.00928962439267031,0,0,37.859344894027,221.007121621528,CDK1;AURKB
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex Homo sapiens R-HSA-75035,1/12,0.00299665302989365,0.00928962439267031,0,0,454.181818181818,2638.91411927659,CDK1
Phosphorylation of Emi1,1/6,0.00149921982162069,0.00959500685837245,0,0,999.5,6499.55901988972,CDK1
Golgi Cisternae Pericentriolar Stack Reorganization Homo sapiens R-HSA-162658,1/14,0.00349539889312047,0.0104861966793614,0,0,384.269230769231,2173.54503857692,CDK1
FOXM1 Signaling in Prostate Cancer,1/11,0.00274720535833692,0.0105377077311754,0,0,499.625,2946.37411950643,CDK1
Microtubule Cytoskeleton,1/12,0.00299665302989365,0.0105377077311754,0,0,454.181818181818,2638.91411927659,AURKB
SCF/FBXO7 Complex,1/14,0.00349539889312047,0.0105377077311754,0,0,384.269230769231,2173.54503857692,CDK1
DNA Replication in DNA Machinery,1/15,0.00374469708393798,0.0105377077311754,0,0,356.803571428571,1993.60946675892,CDC6
G2/M Damage Checkpoint,1/17,0.00424314398899693,0.0105377077311754,0,0,312.171875,1705.22350136349,CDK1
Androgen Receptor and Cell Cycle in Prostate Cancer,1/17,0.00424314398899693,0.0105377077311754,0,0,312.171875,1705.22350136349,CDK1
SIRT7 Signaling in Aging,1/17,0.00424314398899693,0.0105377077311754,0,0,312.171875,1705.22350136349,CDK1
Sister Chromatid Cohesion,1/18,0.00449229270839297,0.0105377077311754,0,0,293.794117647059,1588.07239728978,AURKB
rRNA Transcription and Processing,1/19,0.00474139160939957,0.0105377077311754,0,0,277.458333333333,1484.79734988759,CDK1
SIRT6 Signaling in Aging,1/20,0.00499044069595166,0.0105377077311754,0,0,262.842105263158,1393.12388948095,CDK1
SCF/FBXW7 Complex,1/20,0.00499044069595166,0.0105377077311754,0,0,262.842105263158,1393.12388948095,CDC6
OPTN Associated Glaucoma,1/22,0.00548838944332051,0.0105377077311754,0,0,237.785714285714,1237.70327900363,CDK1
IL4R -> ELK/SRF/HMGY Signaling,1/22,0.00548838944332051,0.0105377077311754,0,0,237.785714285714,1237.70327900363,CDK1
Estrogens/ESR1 Genomic Canonical Signaling,1/22,0.00548838944332051,0.0105377077311754,0,0,237.785714285714,1237.70327900363,CDK1
G2/M DNA damage checkpoint,1/9,0.00224816055240216,0.0105492685760138,0,0,624.59375,3808.54966343072,CDK1
Apoptotic DNA fragmentation and tissue homeostasis,1/10,0.00249770786419674,0.0105492685760138,0,0,555.166666666667,3326.77064151216,TOP2A
Cdc25 and Chk1 regulatory pathway in response to DNA damage,1/10,0.00249770786419674,0.0105492685760138,0,0,555.166666666667,3326.77064151216,CDK1
E2F-enabled inhibition of pre-replication complex formation,1/10,0.00249770786419674,0.0105492685760138,0,0,555.166666666667,3326.77064151216,CDK1
Splicing regulation through Sam68,1/10,0.00249770786419674,0.0105492685760138,0,0,555.166666666667,3326.77064151216,CDK1
Activation of Src by protein tyrosine phosphatase alpha,1/10,0.00249770786419674,0.0105492685760138,0,0,555.166666666667,3326.77064151216,CDK1
Recruitment of NuMA to mitotic centrosomes,1/11,0.00274720535833692,0.0105492685760138,0,0,499.625,2946.37411950643,CDK1
Sonic Hedgehog (SHH) receptor PTCH1 regulation of cell cycle,1/11,0.00274720535833692,0.0105492685760138,0,0,499.625,2946.37411950643,CDK1
BTG family proteins and cell cycle regulation,1/11,0.00274720535833692,0.0105492685760138,0,0,499.625,2946.37411950643,CHAF1B
CDC6 association with the ORC-origin complex,1/11,0.00274720535833692,0.0105492685760138,0,0,499.625,2946.37411950643,CDC6
Association of licensing factors with the pre-replicative complex Homo sapiens R-HSA-69298,1/15,0.00374469708393798,0.0105532372365525,0,0,356.803571428571,1993.60946675892,CDC6
Depolymerisation of the Nuclear Lamina Homo sapiens R-HSA-4419969,1/15,0.00374469708393798,0.0105532372365525,0,0,356.803571428571,1993.60946675892,CDK1
CSNK2A2,2/289,0.00202177609575616,0.0112461295326436,0,0,45.7793263646922,284.004818891694,TOP2A;CDK1
AKAP95 role in mitosis and chromosome dynamics,1/15,0.00374469708393798,0.0119806418512855,0,0,356.803571428571,1993.60946675892,CDK1
Signaling to p38 via RIT and RIN,1/15,0.00374469708393798,0.0119806418512855,0,0,356.803571428571,1993.60946675892,CDK1
Association of licensing factors with the pre-replicative complex,1/15,0.00374469708393798,0.0119806418512855,0,0,356.803571428571,1993.60946675892,CDC6
Cyclin A/B1-associated events during G2/M transition,1/15,0.00374469708393798,0.0119806418512855,0,0,356.803571428571,1993.60946675892,CDK1
Rb tumor suppressor/checkpoint signaling in response to DNA damage,1/16,0.00399394544865564,0.0119806418512855,0,0,333,1839.15090890099,CDK1
Control of cell cycle and breast tumor growth by estrogen-responsive protein Efp,1/16,0.00399394544865564,0.0119806418512855,0,0,333,1839.15090890099,CDK1
Protein kinase A (PKA) at the centrosome,1/16,0.00399394544865564,0.0119806418512855,0,0,333,1839.15090890099,CDK1
SHC-related events,1/17,0.00424314398899693,0.0119806418512855,0,0,312.171875,1705.22350136349,CDK1
SHC1 events in EGFR signaling,1/17,0.00424314398899693,0.0119806418512855,0,0,312.171875,1705.22350136349,CDK1
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest Homo sapiens R-HSA-6804114,1/18,0.00449229270839297,0.0122877418200161,0,0,293.794117647059,1588.07239728978,CDK1
CDK regulation of DNA replication,1/18,0.00449229270839297,0.0123019890406043,0,0,293.794117647059,1588.07239728978,CDC6
Cell cycle progression regulation by PLK3,1/19,0.00474139160939957,0.0123019890406043,0,0,277.458333333333,1484.79734988759,CDK1
FRS2-mediated activation,1/19,0.00474139160939957,0.0123019890406043,0,0,277.458333333333,1484.79734988759,CDK1
DREAM Complex and FOXM1/MYBL2 Promote Cell Cycle Progression in Cancer,1/28,0.00698104063423331,0.0123486131615207,0,0,184.888888888889,917.891480308298,CDK1
EZH2 Methyltransferase Role in Cancer,1/28,0.00698104063423331,0.0123486131615207,0,0,184.888888888889,917.891480308298,CDK1
S/G2 Phase Transition,1/29,0.00722964161170616,0.0123486131615207,0,0,178.276785714286,878.827148224897,CDC6
G2/M Phase Transition,1/30,0.00747819282854126,0.0123486131615207,0,0,172.120689655172,842.662296146542,CDK1
Replication Stress Triggers Genomic Instability,1/32,0.00797514600014876,0.0123486131615207,0,0,161,777.859477043269,CDC6
DNA Damage Checkpoint Impairment in Cancer,1/32,0.00797514600014876,0.0123486131615207,0,0,161,777.859477043269,CDK1
up metaphase anaphase telophase 15min noscapine release vs ctrl HeLa (Human) [19691289],2/359,0.00309996077404552,0.0123998430961821,0,0,36.672268907563,211.832440700011,TOP2A;AURKB
Phosphorylation of the APC/C Homo sapiens R-HSA-176412,1/19,0.00474139160939957,0.0125985548478331,0,0,277.458333333333,1484.79734988759,CDK1
CCND1,1/10,0.00249770786419674,0.0129505540598011,0,0,555.166666666667,3326.77064151216,CDK1
CEP72,1/10,0.00249770786419674,0.0129505540598011,0,0,555.166666666667,3326.77064151216,CHAF1B
CCNB2,1/11,0.00274720535833692,0.0129505540598011,0,0,499.625,2946.37411950643,CDK1
SUGT1,1/12,0.00299665302989365,0.0129505540598011,0,0,454.181818181818,2638.91411927659,AURKB
CDKN1B,1/13,0.00324605087508978,0.0129505540598011,0,0,416.3125,2385.60223672184,CDK1
CCND3,1/13,0.00324605087508978,0.0129505540598011,0,0,416.3125,2385.60223672184,CDK1
CDKN1A,1/13,0.00324605087508978,0.0129505540598011,0,0,416.3125,2385.60223672184,CDK1
CDK17,1/14,0.00349539889312047,0.0129505540598011,0,0,384.269230769231,2173.54503857692,CDK1
CCNB1,1/16,0.00399394544865564,0.0129505540598011,0,0,333,1839.15090890099,CDK1
ICK,1/16,0.00399394544865564,0.0129505540598011,0,0,333,1839.15090890099,CDK1
CDC20,1/17,0.00424314398899693,0.0129505540598011,0,0,312.171875,1705.22350136349,CDK1
HSD3B2,1/18,0.00449229270839297,0.0129505540598011,0,0,293.794117647059,1588.07239728978,TOP2A
CKS2,1/19,0.00474139160939957,0.0129505540598011,0,0,277.458333333333,1484.79734988759,CDK1
INTU,1/19,0.00474139160939957,0.0129505540598011,0,0,277.458333333333,1484.79734988759,TOP2A
TNFRSF8,1/20,0.00499044069595166,0.0129505540598011,0,0,262.842105263158,1393.12388948095,CDC6
CKS1B,1/21,0.00523943997247116,0.0129505540598011,0,0,249.6875,1311.24405900402,CDK1
HSP90AB1,1/23,0.00573728911332865,0.0129505540598011,0,0,226.965909090909,1171.31850515834,AURKB
CDH19,1/23,0.00573728911332865,0.0129505540598011,0,0,226.965909090909,1171.31850515834,TOP2A
TGFBR2,1/24,0.00598613898759602,0.0129505540598011,0,0,217.086956521739,1111.11804759418,CDC6
CDK3,1/24,0.00598613898759602,0.0129505540598011,0,0,217.086956521739,1111.11804759418,CDK1
RBM4B,1/25,0.00623493907047315,0.0129505540598011,0,0,208.03125,1056.29666076894,TOP2A
HIST1H4A,1/26,0.00648368936979889,0.0129505540598011,0,0,199.7,1006.18157701364,CHAF1B
HIST1H3A,1/26,0.00648368936979889,0.0129505540598011,0,0,199.7,1006.18157701364,CHAF1B
ASB3,1/27,0.00673238988859165,0.0129505540598011,0,0,192.009615384615,960.206501870871,TOP2A
HSP90AA1,1/28,0.00698104063423331,0.0129505540598011,0,0,184.888888888889,917.891480308298,AURKB
ASF1B,1/29,0.00722964161170616,0.0129505540598011,0,0,178.276785714286,878.827148224897,CHAF1B
HSP90AA4P,1/29,0.00722964161170616,0.0129505540598011,0,0,178.276785714286,878.827148224897,AURKB
FZR1,1/30,0.00747819282854126,0.0129505540598011,0,0,172.120689655172,842.662296146542,CDK1
IL20RA,1/30,0.00747819282854126,0.0129505540598011,0,0,172.120689655172,842.662296146542,CDC6
PROZ,1/31,0.007726694289036,0.0129505540598011,0,0,166.375,809.093962505696,CDC6
MAGEA10,1/33,0.00822354796912648,0.0129505540598011,0,0,155.9609375,748.730022278245,CDC6
TNFRSF10A,1/35,0.00872020270373213,0.0129505540598011,0,0,146.772058823529,696.009658167556,CDC6
CDK2,1/35,0.00872020270373213,0.0129505540598011,0,0,146.772058823529,696.009658167556,CDK1
CCNA2,1/35,0.00872020270373213,0.0129505540598011,0,0,146.772058823529,696.009658167556,CDK1
HSP90AA5P,1/39,0.00971291554485079,0.0129505540598011,0,0,131.296052631579,608.465136485093,AURKB
GMNN,1/39,0.00971291554485079,0.0129505540598011,0,0,131.296052631579,608.465136485093,CDK1
THBS3,1/39,0.00971291554485079,0.0129505540598011,0,0,131.296052631579,608.465136485093,TOP2A
ISLR,1/39,0.00971291554485079,0.0129505540598011,0,0,131.296052631579,608.465136485093,CDC6
APC/C activator regulation between G1/S and early anaphase,1/21,0.00523943997247116,0.0132364799304535,0,0,249.6875,1311.24405900402,CDK1
LAMP2,1/41,0.0102089737568119,0.0132624456925947,0,0,124.71875,571.771633377479,CDC6
TSPAN3,1/42,0.0104569283345458,0.0132624456925947,0,0,121.670731707317,554.878218723978,CDC6
CCDC102B,1/44,0.0109526884693577,0.0135604714382524,0,0,116,523.643758342585,CDK1
Progesterone-initiated oocyte maturation,1/23,0.00573728911332865,0.0137694938719888,0,0,226.965909090909,1171.31850515834,CDK1
Cyclins and cell cycle regulation,1/23,0.00573728911332865,0.0137694938719888,0,0,226.965909090909,1171.31850515834,CDK1
PCDHB11,1/48,0.0119436128411834,0.0140358897144146,0,0,106.106382978723,469.792232055872,CDC6
BPNT1,1/49,0.0121912198306987,0.0140358897144146,0,0,103.890625,457.850064403937,CDC6
PON2,1/50,0.0124387771927725,0.0140358897144146,0,0,101.765306122449,446.437935140061,CDC6
IKZF5,1/50,0.0124387771927725,0.0140358897144146,0,0,101.765306122449,446.437935140061,CDK1
PCDHGA5,1/51,0.0126862849341824,0.0140358897144146,0,0,99.725,435.522390256301,CDC6
Cyclin A/B1 associated events during G2/M transition Homo sapiens R-HSA-69273,1/22,0.00548838944332051,0.0140412601984096,0,0,237.785714285714,1237.70327900363,CDK1
RAF-independent MAPK1/3 activation Homo sapiens R-HSA-112409,1/23,0.00573728911332865,0.0140412601984096,0,0,226.965909090909,1171.31850515834,CDK1
APC/C:Cdc20 mediated degradation of Cyclin B Homo sapiens R-HSA-174048,1/23,0.00573728911332865,0.0140412601984096,0,0,226.965909090909,1171.31850515834,CDK1
APC/C- and Cdc20-mediated degradation of Nek2A,1/25,0.00623493907047315,0.0142512893039386,0,0,208.03125,1056.29666076894,CDK1
SHC1 events in ERBB2 signaling,1/25,0.00623493907047315,0.0142512893039386,0,0,208.03125,1056.29666076894,CDK1
Retinoic acid receptors-mediated signaling Homo sapiens 5797691b-6195-11e5-8ac5-06603eb7f303,1/28,0.00698104063423331,0.0143103124412457,0,0,184.888888888889,917.891480308298,CDK1
Aurora A signaling Homo sapiens f131cf8e-618b-11e5-8ac5-06603eb7f303,1/31,0.007726694289036,0.0143103124412457,0,0,166.375,809.093962505696,AURKB
ATR signaling pathway Homo sapiens 8991cbac-618b-11e5-8ac5-06603eb7f303,1/39,0.00971291554485079,0.0143103124412457,0,0,131.296052631579,608.465136485093,CDC6
Aurora B signaling Homo sapiens 304a75af-618c-11e5-8ac5-06603eb7f303,1/39,0.00971291554485079,0.0143103124412457,0,0,131.296052631579,608.465136485093,AURKB
Validated transcriptional targets of deltaNp63 isoforms Homo sapiens 7d7360a8-6196-11e5-8ac5-06603eb7f303,1/45,0.0112004940383236,0.0143103124412457,0,0,113.357954545455,509.180964486494,TOP2A
PLK1 signaling events Homo sapiens e5e87977-6194-11e5-8ac5-06603eb7f303,1/46,0.0114482499529966,0.0143103124412457,0,0,110.833333333333,495.415956354284,CDK1
PRKCB,2/338,0.00275324664515273,0.0144140559657996,0,0,39.0059523809524,229.939093285273,TOP2A;CDK1
down metaphase anaphase telophase 15min noscapine release vs ctrl HeLa (Human) [19691289],2/429,0.00439754384249663,0.0145496836224965,0,0,30.5511319281811,165.792106002331,TOP2A;AURKB
down 50nM dasatinib vs ctrl K562 (Human) [19651622],2/451,0.00484989454083217,0.0145496836224965,0,0,29.0215293244246,154.649876662188,TOP2A;CHAF1B
TNFRSF1A,1/55,0.0136758198325556,0.0147755130193842,0,0,92.3194444444444,396.246686077218,CDC6
SKP2,1/56,0.0139230795759582,0.0147755130193842,0,0,90.6363636363636,387.398617490501,CDK1
Kinetochore Assembly,1/40,0.0099609694951761,0.0149414542427642,0,0,127.923076923077,589.607807093397,AURKB
Cell cycle: G2/M checkpoint,1/27,0.00673238988859165,0.0150304518442976,0,0,192.009615384615,960.206501870871,CDK1
down 30min BMP4 vs ctrl hESC (Human) [19664995],2/488,0.00565804459719129,0.0150881189258434,0,0,26.761316872428,138.481168875236,TOP2A;CHAF1B
PRKCG,1/37,0.00921665854482154,0.0151803787797061,0,0,138.604166666667,649.602069210737,TOP2A
down metaphase anaphase telophase 60min noscapine release vs ctrl HeLa (Human) [19691289],2/517,0.00633260781333878,0.0151982587520131,0,0,25.2168284789644,127.648673887708,TOP2A;AURKB
Cell cycle: G1/S checkpoint,1/28,0.00698104063423331,0.0152313613837818,0,0,184.888888888889,917.891480308298,CDK1
Post-translational protein modification Homo sapiens R-HSA-597592,2/521,0.0064284674066086,0.0153294222772974,0,0,25.0173410404624,126.262998552574,TOP2A;AURKB
Retinoic acid receptor-mediated signaling,1/30,0.00747819282854126,0.015606663294347,0,0,172.120689655172,842.662296146542,CDK1
Activation of the pre-replicative complex,1/30,0.00747819282854126,0.015606663294347,0,0,172.120689655172,842.662296146542,CDC6
Stathmin and breast cancer resistance to antimicrotubule agents,1/31,0.007726694289036,0.0157821840797331,0,0,166.375,809.093962505696,CDK1
Ras-GRF Regulation Signaling,1/44,0.0109526884693577,0.0159311832281566,0,0,116,523.643758342585,CDK1
Oncogene Induced Cellular Senescence,1/46,0.0114482499529966,0.0161622352277599,0,0,110.833333333333,495.415956354284,CDK1
LAMP3,1/63,0.0156525100040084,0.0162111257416268,0,0,80.375,334.128840793773,CDC6
C1orf85,1/64,0.0158993733235186,0.0162111257416268,0,0,79.0952380952381,327.570997393791,CDC6
Proteins Involved in Hodgkin Lymphoma,1/50,0.0124387771927725,0.01658503625703,0,0,101.765306122449,446.437935140061,AURKB
Proteins Involved in Endometrial Cancer,1/50,0.0124387771927725,0.01658503625703,0,0,101.765306122449,446.437935140061,TOP2A
Activation of the pre-replicative complex Homo sapiens R-HSA-68962,1/30,0.00747819282854126,0.0173867983263584,0,0,172.120689655172,842.662296146542,CDC6
Integrated cancer pathway,1/35,0.00872020270373213,0.0174404054074643,0,0,146.772058823529,696.009658167556,CDK1
Signaling to ERKs,1/36,0.00896845548275989,0.0175708515580602,0,0,142.571428571429,672.087674444452,CDK1
beta-Cell Destruction in Diabetes Mellitus Type 1,1/55,0.0136758198325556,0.0177416041070991,0,0,92.3194444444444,396.246686077218,TOP2A
Aurora B signaling,1/39,0.00971291554485079,0.0182831351432486,0,0,131.296052631579,608.465136485093,AURKB
FRS2-mediated cascade,1/39,0.00971291554485079,0.0182831351432486,0,0,131.296052631579,608.465136485093,CDK1
Proteins Involved in Female Infertility,1/60,0.0149116228452911,0.0184867165879038,0,0,84.4745762711864,355.267487083311,CDK1
Proteins Involved in Diffuse Large-B-Cell Lymphoma,1/61,0.0151586347698374,0.0184867165879038,0,0,83.0625,347.96417553925,CDK1
TGF-beta Signaling,1/62,0.0154055971565865,0.0184867165879038,0,0,81.6967213114754,340.922410114916,CDK1
AP-1 transcription factor network Homo sapiens 3ce2f9c5-6189-11e5-8ac5-06603eb7f303,1/69,0.01713294726931,0.0190366080770111,0,0,73.2610294117647,297.934432634127,CDK1
Nuclear Pore Complex (NPC) Disassembly Homo sapiens R-HSA-3301854,1/34,0.00847190020148784,0.0192167492375212,0,0,151.227272727273,721.505386318462,CDK1
Regulation of TP53 Degradation Homo sapiens R-HSA-6804757,1/35,0.00872020270373213,0.0193090202725497,0,0,146.772058823529,696.009658167556,CDK1
p73 transcription factor network Homo sapiens a88c505e-6194-11e5-8ac5-06603eb7f303,1/78,0.0193502634667733,0.0193502634667733,0,0,64.6688311688312,255.121723496479,CDK1
Regulation of TP53 Expression and Degradation Homo sapiens R-HSA-6806003,1/36,0.00896845548275989,0.0193968920906202,0,0,142.571428571429,672.087674444452,CDK1
Activation of ATR in response to replication stress Homo sapiens R-HSA-176187,1/37,0.00921665854482154,0.0194806646515546,0,0,138.604166666667,649.602069210737,CDC6
Chronic Myeloid Leukemia,1/70,0.0173795135752015,0.0202257663204265,0,0,72.195652173913,292.570219819561,CDK1
Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway,1/72,0.0178724977648703,0.0202257663204265,0,0,70.1549295774648,282.337965850601,TOP2A
TGFB Signaling activation by Blocking of Tumor Suppressors,1/73,0.0181189156620487,0.0202257663204265,0,0,69.1770833333333,277.455364357132,CDK1
down Rapamycin vs Ctrl Exp1 MEFs (Mouse) [21659605],2/637,0.00950062299130188,0.0207286319810223,0,0,20.3254593175853,94.6434261742825,TOP2A;AURKB
PPAR-alpha pathway WP2878,1/26,0.00648368936979889,0.0208101080917796,0,0,199.7,1006.18157701364,CDK1
Gastric Cancer Network 1 WP2361,1/29,0.00722964161170616,0.0208101080917796,0,0,178.276785714286,878.827148224897,TOP2A
Gastric Cancer Network 2 WP2363,1/31,0.007726694289036,0.0208101080917796,0,0,166.375,809.093962505696,TOP2A
ATM Signaling Pathway WP2516,1/40,0.0099609694951761,0.0208101080917796,0,0,127.923076923077,589.607807093397,CDK1
DNA Replication WP466,1/42,0.0104569283345458,0.0208101080917796,0,0,121.670731707317,554.878218723978,CDC6
Integrated Cancer Pathway WP1971,1/44,0.0109526884693577,0.0208101080917796,0,0,116,523.643758342585,CDK1
Condensation of Prophase Chromosomes Homo sapiens R-HSA-2299718,1/41,0.0102089737568119,0.021098545764078,0,0,124.71875,571.771633377479,CDK1
Polo-like kinase 1 (PLK1) pathway,1/46,0.0114482499529966,0.0211352306824552,0,0,110.833333333333,495.415956354284,CDK1
Delta Np63 pathway,1/47,0.0116959562183021,0.0211851282444718,0,0,108.41847826087,482.300914498126,TOP2A
MANSC1,1/88,0.0218092535740446,0.0218092535740446,0,0,57.2068965517241,218.84045903048,CDC6
PPP2CA,1/88,0.0218092535740446,0.0218092535740446,0,0,57.2068965517241,218.84045903048,CDK1
Prader-Willi and Angelman Syndrome WP3998,1/61,0.0151586347698374,0.0239210412649859,0,0,83.0625,347.96417553925,CDC6
G1 to S cell cycle control WP45,1/64,0.0158993733235186,0.0239210412649859,0,0,79.0952380952381,327.570997393791,CDK1
DNA damage response WP707,1/68,0.016886331477543,0.0239210412649859,0,0,74.3582089552239,303.474497748396,CDK1
miRNA regulation of DNA damage response WP1530,1/71,0.0176260304057791,0.0239210412649859,0,0,71.1607142857143,287.373896428125,CDK1
TP53 Regulates Transcription of Cell Cycle Genes Homo sapiens R-HSA-6791312,1/48,0.0119436128411834,0.0241468694397838,0,0,106.106382978723,469.792232055872,CDK1
CDK-mediated phosphorylation and removal of Cdc6 Homo sapiens R-HSA-69017,1/50,0.0124387771927725,0.0245796770599785,0,0,101.765306122449,446.437935140061,CDC6
Nuclear Envelope Breakdown Homo sapiens R-HSA-2980766,1/51,0.0126862849341824,0.0245796770599785,0,0,99.725,435.522390256301,CDK1
RET knockout 270 GSE32093,2/300,0.00217647688711148,0.0246667380539301,0,0,44.0648769574944,270.119802769701,CDC6;AURKB
DNA IR-damage and cellular response via ATR WP4016,1/80,0.0198424566057452,0.0251337783672772,0,0,63.0253164556962,247.054914696706,CDK1
Autodegradation of Cdh1 by Cdh1-APC/C,1/58,0.0144174503390076,0.0256310228249025,0,0,87.4473684210526,370.717026091757,CDC6
Follicular Lymphoma,1/97,0.0240181254075563,0.0262015913536978,0,0,51.8203125,193.23517335892,CDK1
Licensing factor removal from origins,1/61,0.0151586347698374,0.026458707961898,0,0,83.0625,347.96417553925,CDC6
CDT1 association with the CDC6:ORC:origin complex Homo sapiens R-HSA-68827,1/58,0.0144174503390076,0.0268009379527354,0,0,87.4473684210526,370.717026091757,CDC6
The role of GTSE1 in G2/M progression after G2 checkpoint Homo sapiens R-HSA-8852276,1/59,0.0146645613684728,0.0268009379527354,0,0,85.9353448275862,362.846652966345,CDK1
Generic Transcription Pathway Homo sapiens R-HSA-212436,2/812,0.0151702868863124,0.0268009379527354,0,0,15.7901234567901,66.1356147978604,CDK1;AURKB
Assembly of the pre-replicative complex Homo sapiens R-HSA-68867,1/67,0.0166396661964727,0.0268009379527354,0,0,75.4886363636364,309.198880692339,CDC6
Loss of Nlp from mitotic centrosomes Homo sapiens R-HSA-380259,1/69,0.01713294726931,0.0268009379527354,0,0,73.2610294117647,297.934432634127,CDK1
Loss of proteins required for interphase microtubule organization?from the centrosome Homo sapiens R-HSA-380284,1/69,0.01713294726931,0.0268009379527354,0,0,73.2610294117647,297.934432634127,CDK1
Switching of origins to a post-replicative state Homo sapiens R-HSA-69052,1/70,0.0173795135752015,0.0268009379527354,0,0,72.195652173913,292.570219819561,CDC6
Orc1 removal from chromatin Homo sapiens R-HSA-68949,1/70,0.0173795135752015,0.0268009379527354,0,0,72.195652173913,292.570219819561,CDC6
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 Homo sapiens R-HSA-174178,1/71,0.0176260304057791,0.0268009379527354,0,0,71.1607142857143,287.373896428125,AURKB
Cdc20:Phospho-APC/C mediated degradation of Cyclin A Homo sapiens R-HSA-174184,1/71,0.0176260304057791,0.0268009379527354,0,0,71.1607142857143,287.373896428125,CDK1
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint Homo sapiens R-HSA-179419,1/72,0.0178724977648703,0.0268009379527354,0,0,70.1549295774648,282.337965850601,CDK1
Removal of licensing factors from origins Homo sapiens R-HSA-69300,1/72,0.0178724977648703,0.0268009379527354,0,0,70.1549295774648,282.337965850601,CDC6
AURKA Activation by TPX2 Homo sapiens R-HSA-8854518,1/72,0.0178724977648703,0.0268009379527354,0,0,70.1549295774648,282.337965850601,CDK1
APC/C:Cdc20 mediated degradation of mitotic proteins Homo sapiens R-HSA-176409,1/74,0.018365284102935,0.0268009379527354,0,0,68.2260273972603,272.719430604103,CDK1
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins Homo sapiens R-HSA-176814,1/75,0.0186116030985804,0.0268009379527354,0,0,67.3006756756757,268.123877599833,CDK1
Regulation of DNA replication Homo sapiens R-HSA-69304,1/75,0.0186116030985804,0.0268009379527354,0,0,67.3006756756757,268.123877599833,CDC6
G2/M DNA damage checkpoint Homo sapiens R-HSA-69473,1/78,0.0193502634667733,0.0268009379527354,0,0,64.6688311688312,255.121723496479,CDK1
Regulation of APC/C activators between G1/S and early anaphase Homo sapiens R-HSA-176408,1/79,0.0195963847396345,0.0268009379527354,0,0,63.8365384615385,251.031453818202,CDK1
Centrosome maturation Homo sapiens R-HSA-380287,1/79,0.0195963847396345,0.0268009379527354,0,0,63.8365384615385,251.031453818202,CDK1
Recruitment of mitotic centrosome proteins and complexes Homo sapiens R-HSA-380270,1/79,0.0195963847396345,0.0268009379527354,0,0,63.8365384615385,251.031453818202,CDK1
DNA Replication Pre-Initiation Homo sapiens R-HSA-69002,1/82,0.0203344521241591,0.0270157721078113,0,0,61.462962962963,239.425203466437,CDC6
M/G1 Transition Homo sapiens R-HSA-68874,1/82,0.0203344521241591,0.0270157721078113,0,0,61.462962962963,239.425203466437,CDC6
BL2593 (RPL7A),3/251,1.91711908728812e-05,0.0270313791307625,0,0,119.4375,1297.34229342888,TOP2A;CHAF1B;AURKB
G1 to S cell cycle control,1/67,0.0166396661964727,0.0278072217203224,0,0,75.4886363636364,309.198880692339,CDK1
Activation of NF-kappaB in B cells,1/68,0.016886331477543,0.0278072217203224,0,0,74.3582089552239,303.474497748396,CDC6
NCAM signaling for neurite out-growth,1/70,0.0173795135752015,0.0278072217203224,0,0,72.195652173913,292.570219819561,CDK1
AP-1 transcription factor network,1/70,0.0173795135752015,0.0278072217203224,0,0,72.195652173913,292.570219819561,CDK1
MicroRNA regulation of DNA damage response,1/70,0.0173795135752015,0.0278072217203224,0,0,72.195652173913,292.570219819561,CDK1
Regulation of PLK1 Activity at G2/M Transition Homo sapiens R-HSA-2565942,1/87,0.0215635767386735,0.028245248404178,0,0,57.875,222.051885978165,CDK1
Regulation of TP53 Activity through Phosphorylation Homo sapiens R-HSA-6804756,1/89,0.0220548810634028,0.0284875547068952,0,0,56.5539772727273,215.709386871844,AURKB
RANKL regulation of apoptosis and immune response,1/74,0.018365284102935,0.028902742194783,0,0,68.2260273972603,272.719430604103,CDK1
MAPK6/MAPK4 signaling Homo sapiens R-HSA-5687128,1/92,0.0227914675292109,0.0290357052084468,0,0,54.6813186813187,206.770245759688,CDK1
AURKB,1/77,0.0191040927721202,0.0297174776455204,0,0,65.5230263157895,259.330485674006,AURKB
Synthesis of DNA Homo sapiens R-HSA-69239,1/97,0.0240181254075563,0.0297824755053698,0,0,51.8203125,193.23517335892,CDC6
Anchoring of the basal body to the plasma membrane Homo sapiens R-HSA-5620912,1/97,0.0240181254075563,0.0297824755053698,0,0,51.8203125,193.23517335892,CDK1
LYN,1/82,0.0203344521241591,0.0298449907730082,0,0,61.462962962963,239.425203466437,CDK1
IGF1R,1/86,0.0213178505521487,0.0298449907730082,0,0,58.5588235294118,225.346679757786,CDK1
Signaling by SCF-KIT,1/78,0.0193502634667733,0.0298611576984907,0,0,64.6688311688312,255.121723496479,CDK1
p73 transcription factor network,1/79,0.0195963847396345,0.0298611576984907,0,0,63.8365384615385,251.031453818202,CDK1
PXK knockdown 96h HA1E,2/300,0.00217647688711148,0.0301597511499734,0,0,44.0648769574944,270.119802769701,CDC6;AURKB
GPR128 knockdown 96h HA1E,2/300,0.00217647688711148,0.0301597511499734,0,0,44.0648769574944,270.119802769701,CDK1;AURKB
ADORA2B knockdown 96h HEPG2,2/300,0.00217647688711148,0.0301597511499734,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
PIM3 knockdown 96h HEPG2,2/300,0.00217647688711148,0.0301597511499734,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
CSNK1A1L knockdown 96h PC3,2/300,0.00217647688711148,0.0301597511499734,0,0,44.0648769574944,270.119802769701,CHAF1B;CDC6
GPRC5A knockdown 96h A375,2/300,0.00217647688711148,0.0301597511499734,0,0,44.0648769574944,270.119802769701,CDK1;AURKB
GPR150 knockdown 96h PC3,2/300,0.00217647688711148,0.0301597511499734,0,0,44.0648769574944,270.119802769701,CHAF1B;CDK1
Metabolism of proteins Homo sapiens R-HSA-392499,2/1074,0.0258447049267778,0.0313762866699287,0,0,11.7680348258706,43.0198110676833,TOP2A;AURKB
DNA Replication Homo sapiens R-HSA-69306,1/105,0.0259782158449948,0.0313762866699287,0,0,47.8149038461538,174.548160380973,CDC6
Mitotic Prophase Homo sapiens R-HSA-68875,1/107,0.0264677460982749,0.03155769727102,0,0,46.9080188679245,170.361875846808,CDK1
Progesterone-mediated oocyte maturation,1/86,0.0213178505521487,0.0317225506531557,0,0,58.5588235294118,225.346679757786,CDK1
Mitotic G2-G2/M phases,1/87,0.0215635767386735,0.0317225506531557,0,0,57.875,222.051885978165,CDK1
DNA replication pre-Initiation,1/88,0.0218092535740446,0.0317225506531557,0,0,57.2068965517241,218.84045903048,CDC6
Gap junction pathway,1/90,0.0223004592144074,0.0319528967848225,0,0,55.9157303370786,212.655798455924,CDK1
Signaling by ERBB4,1/93,0.0230368977064391,0.0325226791149728,0,0,54.0842391304348,203.933174379974,CDK1
up Rapamycin vs Ctrl Exp2 MEFs (Mouse) [21659605],2/844,0.016336845189181,0.0326736903783619,0,0,15.1646872525732,62.3925622955745,TOP2A;CHAF1B
M phase pathway,1/96,0.0237728924186839,0.0329391434160772,0,0,52.3684210526316,195.81648814875,AURKB
Mitochondrial pathway of apoptosis: BH3-only Bcl-2 family,1/97,0.0240181254075563,0.0329391434160772,0,0,51.8203125,193.23517335892,CDK1
RHO GTPases Activate Formins Homo sapiens R-HSA-5663220,1/114,0.0281795523721255,0.0331733970962996,0,0,43.9867256637168,156.995602705958,AURKB
UBC,2/540,0.00689307193465486,0.0333826724702115,0,0,24.1102850061958,120.002637313716,TOP2A;CDK1
MAPK14,2/552,0.00719436877608936,0.0333826724702115,0,0,23.569696969697,116.303648502213,CHAF1B;CDC6
CSNK2A1,2/564,0.00750172415060933,0.0333826724702115,0,0,23.0521945432977,112.785683348171,TOP2A;CDK1
Signaling by ERBB2,1/102,0.0252435512890159,0.0341321256865567,0,0,49.2425742574257,181.172518428561,CDK1
Proteins Involved in Hepatocellular Carcinoma,1/130,0.0320832120073854,0.0342220928078778,0,0,38.5,132.417761478983,CDK1
Spinal Cord Injury WP2431,1/118,0.0291566458207325,0.0346235169121199,0,0,42.474358974359,150.149934338034,CDK1
ESR1,2/591,0.00821530205309015,0.0348172325107154,0,0,21.9649122807018,105.47016601976,TOP2A;CDK1
PRKG1,1/106,0.026223005581082,0.0349640074414427,0,0,47.3571428571429,172.432953709799,AURKB
Signaling by insulin receptor,1/109,0.0269570795265086,0.0352865130236008,0,0,46.0347222222222,166.346898022579,CDK1
Signaling by interleukins,1/109,0.0269570795265086,0.0352865130236008,0,0,46.0347222222222,166.346898022579,CDK1
Signaling by EGFR in cancer,1/111,0.027446216189274,0.0352865130236008,0,0,45.1931818181818,162.493303828439,CDK1
S phase,1/112,0.0276907107529675,0.0352865130236008,0,0,44.7837837837838,160.624128645117,CDC6
Oocyte meiosis,1/113,0.027935156143684,0.0352865130236008,0,0,44.3816964285714,158.791909424441,CDK1
S Phase Homo sapiens R-HSA-69242,1/124,0.0306208123732578,0.0355966943839122,0,0,40.390243902439,140.803433983989,CDC6
p53 activity regulation,1/118,0.0291566458207325,0.0363511428414328,0,0,42.474358974359,150.149934338034,CDK1
TGF-beta Signaling Pathway WP366,1/132,0.0325702861721075,0.0364020845452967,0,0,37.9083969465649,129.811803825291,CDK1
Signaling by PDGF,1/122,0.0301329532619136,0.0370867117069705,0,0,41.0619834710744,143.804646986253,CDK1
Signaling by FGFR in disease,1/128,0.0315959416881767,0.0383950683805691,0,0,39.1102362204724,135.115173177333,CDK1
NGF signaling via TRKA from the plasma membrane,1/136,0.033543846303411,0.0402526155640932,0,0,36.7777777777778,124.856945855798,CDK1
CDK2,2/675,0.0106277592665288,0.0429941170327757,0,0,19.1401684001981,86.9783974270115,CHAF1B;CDC6
Pperoxisome,1/104,0.0257333768915334,0.0432970264083246,0,0,48.2815533980583,176.708864043101,TOP2A
PI3K/AKT/mTOR  Signaling,1/105,0.0259782158449948,0.0432970264083246,0,0,47.8149038461538,174.548160380973,CDK1
Proteins with Altered Expression in Cancer-Associated Sustaining of Proliferative Signaling,1/175,0.0429950489483144,0.0446491817848192,0,0,28.4784482758621,89.6122876831694,CDK1
Proteins Involved in Glioblastoma,1/178,0.0437189904976355,0.0446491817848192,0,0,27.9915254237288,87.6127105787506,AURKB
Separation of Sister Chromatids Homo sapiens R-HSA-2467813,1/162,0.039852900931599,0.045757034402947,0,0,30.7981366459627,99.2488456973426,AURKB
Toll receptor cascades,1/159,0.0391266191990589,0.0463722894211069,0,0,31.3876582278481,101.725901420768,CDK1
Barasertib,1/5,0.0012494733811349,0.0469662406439863,0,0,1249.4375,8352.53105828692,AURKB
Tozasertib,1/8,0.00199856343165899,0.0469662406439863,0,0,713.857142857143,4436.8553176414,AURKB
Mitotic Anaphase Homo sapiens R-HSA-68882,1/173,0.0425121777321948,0.0470416417905087,0,0,28.8125,90.9888581843975,AURKB
G2/M Transition Homo sapiens R-HSA-69275,1/173,0.0425121777321948,0.0470416417905087,0,0,28.8125,90.9888581843975,CDK1
Mitotic Metaphase and Anaphase Homo sapiens R-HSA-2555396,1/174,0.0427536377036415,0.0470416417905087,0,0,28.6445086705202,90.2961131758246,AURKB
Mitotic G2-G2/M phases Homo sapiens R-HSA-453274,1/175,0.0429950489483144,0.0470416417905087,0,0,28.4784482758621,89.6122876831694,CDK1
Spermatogenesis,1/135,0.0333005297772172,0.0475721853960246,0,0,37.0541044776119,126.064806275557,CDK1
Apoptosis,1/161,0.0396108558318906,0.0490145198704161,0,0,30.9921875,100.062990050538,TOP2A
IL-2/STAT5 Signaling,1/199,0.0487743240689484,0.0490145198704161,0,0,24.9962121212121,75.5023397858544,CDC6
Glycolysis,1/200,0.0490145198704161,0.0490145198704161,0,0,24.8693467336683,74.9969644756718,CDK1
Assembly of the primary cilium Homo sapiens R-HSA-5617833,1/187,0.0458881869997037,0.0496232719880516,0,0,26.625,82.0462037551873,CDK1
